876899-41-1Relevant academic research and scientific papers
QUINOLINES THAT MODULATE SERCA AND THEIR USE FOR TREATING DISEASE
-
Paragraph 0683, (2019/06/07)
Provided herein are quinolines, e.g., a compound of Formula I, pharmaceutical compositions thereof, and methods of their use for treating, preventing, or ameliorating one or more symptoms of a neurological disease, neurodegenerative disorder, or diabetes. Also provided herein are methods of their use for modulating the activity of a sarcoplasmic/endoplasmic reticulum C2+ ATPase.
QUINOLINES AND THEIR USE FOR TREATING ENDOPLASMIC RETICULUM STRESS-CAUSED DISEASES
-
Page/Page column 201, (2016/03/22)
Provided herein are quinolines, e.g., a compound of Formula (I) or (IB), pharmaceutical compositions thereof, and methods of their use for treating, preventing, or ameliorating one or more symptoms of an endoplasmic reticulum stress-caused disease. Also provided herein are methods of their use for reducing endoplasmic reticulum stress and modulating the activity of a sarcoplasmic/endoplasmic reticulum Ca2+ ATPase.
Synthesis, characterization and ethylene oligomerization of nickel complexes bearing N-(2-(1H-benzo[d]imidazol-2-yl)quinolin-8-yl)benzamide derivatives
Wang, Kefeng,Shen, Miao,Sun, Wen-Hua
experimental part, p. 4085 - 4095 (2009/09/05)
A series of N-(2-(1-R-1H-benzo[d]imidazol-2-yl)quinolin-8-yl)-2-R 1-4-R2-benzamide derivatives (5-12) was synthesized and characterized. These compounds 5-11 (5: R = H, R1 = H, R2 = H; 6: R = H, R1 =
